01/14/2009
https://www.congress.gov...
"the review of the 510(k) products. It's become particularly burdensome, causing product approval delays and the frustration for the manufacturers, providers, and obviously the patients."
"I would just urge you to help improve upon the efforts to provide frequent, transparent communication with the companies."
"But in North Carolina, we have about 19,000 biopharmaceutical jobs in our State, and it is such an important part of our economy, and I want to make sure we do all we can to invest in this sector and ..."
"DOD plans to apply approximately $6.2 billion towards the design, development, procurement, test and evaluation, and deployment of the systems identified in question #4 over fiscal years 2012 to 2016."